[UTStarcom Announces Plans for a Cash Tender Offer for up to US$30 Million of its Outstanding Ordinary Shares and Plans for a Reverse Share Split BEIJING, November 19, 2012 UTStarcom Holdings Corp. (UTStarcom or the Company), a leading provider of media operational support services and broadband equipment products and services, today announced two significant actions to enhance liquidity. The]
[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]
[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]
[SCHEDULE 14A INFORMATION þ o Check the appropriate box: o Preliminary Proxy Statement o þ Definitive Proxy Statement o Definitive Additional Materials o CHINA PHARMA HOLDINGS, INC . Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]
[SCHEDULE 14A INFORMATION þ o Check the appropriate box: o Preliminary Proxy Statement o þ Definitive Proxy Statement o Definitive Additional Materials o CHINA PHARMA HOLDINGS, INC . Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]
[TABLE OF CONTENTS PART I. FINANCIAL INFORMATION PAGE Item 1. Financial Statements Consolidated Balance Sheets as of September 30, 2012 (Unaudited) and December 31, 2011 F1-F2 Consolidated Statements of Income and Comprehensive Income for the Nine and Three Months Ended September 30, 2012 and 2011 (Unaudited) F3-F4 Consolidated Statements of Cash Flows F5-F6 Notes to Consolidated Financial Statements (Unaudited) F7-F32] [CERTIFICATION I, Handong Cheng, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of ChinaNet Online Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zhige Zhang certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of ChinaNet Online Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. November 19, 2012 Handong Cheng Chief Executive Officer Zhige Zhang Chief Financial Officer (Principal Accounting and Financial Officer)]
[Yingli Green Energy Announces Preliminary Financial Results for Third Quarter 2012 BAODING, China; November 16, 2012 Yingli Green Energy Holding Company Limited (NYSE: YGE) (Yingli Green Energy or the Company), a leading solar energy company and one of the worlds largest vertically integrated photovoltaic (PV) manufacturers, which markets its products under the brand Yingli Solar, today announced its preliminary financial]
[Yingli Green Energy Announces Preliminary Financial Results for Third Quarter 2012 BAODING, China; November 16, 2012 Yingli Green Energy Holding Company Limited (NYSE: YGE) (Yingli Green Energy or the Company), a leading solar energy company and one of the worlds largest vertically integrated photovoltaic (PV) manufacturers, which markets its products under the brand Yingli Solar, today announced its preliminary financial]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013 2Q13 New Subscribers Up 33.0% to 18,491 2Q13 Revenue Up 30.5% YOY to RMB128.5 Million 2Q13 Operating Income Up 24.7% to RMB47.0 Million Conference Call to be Held November 20, 2012 at 8:00 a.m. ET HONG KONG, China, November 19, 2012 — China]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013 2Q13 New Subscribers Up 33.0% to 18,491 2Q13 Revenue Up 30.5% YOY to RMB128.5 Million 2Q13 Operating Income Up 24.7% to RMB47.0 Million Conference Call to be Held November 20, 2012 at 8:00 a.m. ET HONG KONG, China, November 19, 2012 — China]
